Skip to main content

Table 2 Comparison between subjects with a FINDRISC score < 13 vs subjects without the metabolic syndrome and subjects with a FINDRISC ≥ 13 vs subjects with the metabolic syndrome

From: Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome

  FINDRISC < 13 Metabolic healthy P1 FINDRISC ≥ 13 Metabolic syndrome P2
Number of cases 389 339   262 312  
Age (years) 40 ± 12 41 ± 13 0.89 47 ± 12 45 ± 12 0.83
Weight (kg) 108.3 ± 22.0 104.7 ± 20.3 0.32 110.9 ± 19.9 114 ± 20.9 0.02
BMI (kg/m2) 37.8 ± 6.2 37.5 ± 6.2 0.91 38.9 ± 5.8 39.0 ± 5.8 0.85
Waist (cm) 113.9 ± 14.9 113.8 ± 15.6 0.98 119.4 ± 13.3 120.8 ± 13.2 0.88
Systolic BP (mmHg) 126 ± 15 123 ± 13 0.76 132 ± 14 134 ± 14 0.82
Diastolic BP (mmHg) 75 ± 11 73 ± 10 0.89 78 ± 11 80 ± 11 0.79
Triglycerides (mg/dl) 125 (90–177) 106 (80–130) < 0.001 150 (108–198) 179 (150–1229) 0.01
Cholesterol (mg/dl) 196 (175–226) 197 (172–219) 0.86 202 (173–229) 201 (175–235) 0.87
HDL cholesterol (mg/dl) 48 (40–60) 56 (48–66) < 0.001 49 (40–60) 42 (40–60) 0.05
CT visceral fat (cm2) 169 (115–225) 155 (102–212) < 0.001 206 (148–277) 210 (158–267) 0.20
CT subcutaneous fat (cm2) 592 (592) 601 (149) 0.10 593 (138) 584 (137) 0.06
Total fat (cm2) 773 ± 175 771 ± 183 0.68 812 ± 166 806 ± 159 0.52
Fasting glucose (mg/dl) 84 (79–91) 83 (78–91) 0.84 90 (83–99) 92 (82–101) 0.83
2-h OGTT glucose (mg/dl) 133 (114–154) 131 (113–155) 0.79 155 (129–186) 152 (150–184) 0.68
Hba1c (%) 5.4 (5.2–5.6) 5.5 (5.2–5.6) 0.56 5.6 (5.4–5.9) 5.6 (5.4–5.9) 0.91
HbA1c (mmol/mol) 36 (33–38) 36 (33–38) 0.97 38 (36–41) 38 (36–40) 0.98
Microalbuminuria (μg/min) 8.0 (5–11) 11 (5–12) 0.43 10.0 (6–15) 9.0 (6–15) 0.66
FINDRISC score 10 ± 2 11 ± 4 0.74 16 ± 3 13 ± 4 0.03
HOMA-S 2.9 (1.9–4.8) 2.7 (1.8–4.2) 0.63 3.9 (2.5–6.0) 4.2 (2.7–6.0) 0.04
HOMA-B (%) 252 (164–392) 233 (152–369) < 0.03 236 (147–337) 261 (165–385) < 0.01
Metbalic syndrome 228/161    111/151   
  1. Data are expressed as mean ± standard deviation or median (range)
  2. BMI body mass index, BP blood pressure, HDL high density lipoprotein, OGTT oral glucose tolerance test, HOMA-S homeostasis model assessment of insulin resistance, HOMA-B homeostasis model assessment of beta-cell function, P1 P value for the comparison between FINDRISC < 13 and Metabolic Healthy, P2 P value for the comparison between FINDRISC ≥ 13 and metabolic syndrome